Caitong International Asset Management’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
Caitong International Asset Management's RXST Position: Q1 2026 in Review
Caitong International Asset Management reduced its RxSight (RXST) stake by 97% in Q1 2026, selling an estimated $34.2K and leaving 134 shares worth $825. The position accounts for ﹤0.01% of the portfolio, ranked #1495.
Caitong International Asset Management first reported a position in RXST in Q4 2024 and has held it in 6 quarters since. The position peaked at $44.3K in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- Caitong International Asset Management held 134 shares of RxSight worth $825 as of Q1 2026.
- Caitong International Asset Management sold 4,115 RxSight shares in Q1 2026, an estimated $34.2K.
- RxSight made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1495 holding.
- Caitong International Asset Management first reported a position in RxSight in Q4 2024 and has held it in 6 quarters since.
- Caitong International Asset Management's RxSight position peaked at $44.3K in Q4 2025.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.